Enter the GS Ori-Go™ era
Evolved expression technology.
Faster. Simpler. Better.
Faster, simpler process*
Rapid scale up and tox material supply and reduced time in the lab
Streamline your workflow
Streamline your cloning process by going direct from bulk pools to clonal cell line
Rapid scale-up
Up to 97% stability of bulk pools allowing for rapid scale up and tox material supply
Higher titers
Lead clone titers of up to 11 g/L across molecule formats
Accelerate timelines
Save up to 2 weeks in the lab
Simplify your process
Remove the complexity of enriched pools and MSX selection
Integrated service
GS Ori-Go™ vectors power our accelerated 6 months to IND services timeline**
*When compared to GS Gene Expression System® without GS Ori-Go™
**Based on the use of pool material. From DNA transfection to delivery of IND-enabling CMC modules. Typical timelines. Subject to agreement with regulatory authorities.
Faster Clones, Simpler Process: What’s Changing in CHO Expression?
Wednesday, 3 June 2026
8:00am PT | 11:00am ET | 4:00pm BST | 5:00pm CET
We will discuss how advanced vector technology elevates protein expression performance through improved glutamine synthetase selection stringency combined with a high strength gene promoter to control product expression.
Peter O'Callaghan, Ph.D.
Senior Director
Head of Expression System Sciences
GS Ori-Go™. Redefining expression.
The world’s leading expression system, now even better with GS Ori-Go™
GS Ori-Go™ vectors elevate performance by improving titers and stability across bulk pools, leading to quicker turnaround. Delivering lead clone titers of up to 11 g/L and a simplified process, skipping the need for enriched pools, GS Ori-Go™ vectors get you to your stable cell line faster. This represents the latest advancement in our relentless pursuit of innovation. Backed by 30 years of proven platform expertise.
Contact our technical experts to learn more about
GS Ori-Go™
